Important Reminder for Picard Medical Investors: Class Action Deadline Approaches Soon

Crucial Notice for Investors: Picard Medical Securities Class Action

Investors affiliated with Picard Medical, Inc. (NYSE: PMI) are being reminded of an impending deadline related to a securities class action lawsuit. The law firm Faruqi & Faruqi, LLP has announced that individuals who purchased shares of Picard between September 2, 2025, and October 31, 2025, can still take action until April 13, 2026, to seek the lead plaintiff role in this ongoing litigation.

Faruqi & Faruqi, a prominent securities law firm with a track record of recovering substantial amounts for investors, is currently investigating potential claims against Picard Medical regarding certain actions taken by the company and its executives. The firm asserts that these individuals may have engaged in fraudulent activities that violated federal securities laws, including making misleading statements and omitting critical information regarding share manipulation schemes and misinformation tactics employed on social media.

Background of the Case

On October 24, 2025, the shares of Picard Medical plummeted from $13.20 to $5.31, reflecting a shocking loss of almost 60% in value in just one day. This drastic drop raised suspicions among investors about the company’s operational integrity and transparency. Allegations have surfaced that insiders might have coordinated the selling of shares during a period when misinformation was rampant in the market, affecting stock prices significantly.

What Investors Should Know

As the deadline looms closer, affected investors are encouraged to reach out to Faruqi & Faruqi directly. According to Senior Partner James (Josh) Wilson, anyone who suffered losses due to Picard Medical's alleged misconduct should discuss their options with the firm. Those interested can contact him at 877-247-4292 or 212-983-9330 (Ext. 1310) to explore their eligibility and the next steps.

The timeframe to assert one’s rights as a lead plaintiff allows investors to play a pivotal role in the class action process. The lead plaintiff serves as a representative for the entire class against the accused party, making it a significant position for ensuring all affected shareholders can seek potential recoveries.

Legal Rights and Next Steps

If you are among those who purchased Picard Medical securities within the specified dates, now is the time to consider your legal rights. Filing as lead plaintiff can significantly impact the litigation outcome, and it is critical to act before the April 13 deadline.

Interested individuals, including whistleblowers, former employees, and current shareholders, are invited to forward any information pertinent to the misconduct or actions at Picard Medical.

For continuous updates, investors can keep track of the developments via Faruqi & Faruqi’s website or their social media platforms such as LinkedIn, X, and Facebook.

Conclusion

In summary, time is of the essence for investors in Picard Medical. With a deadline in place for the securities class action, it is essential to take swift action, understand your rights, and pursue the necessary steps to participate in ensuring corporate accountability in these legally challenging times. Make sure to consult with a legal professional who can guide you through the process effectively.